Tenaya Therapeutics, Inc. (TNYA) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 77 transactions totaling $112.1M, demonstrating a bullish sentiment with $111.3M in net insider flow. The most recent transaction on Feb 3, 2026 involved a transaction of 952,250 shares valued at $0.
No significant insider buying has been recorded for TNYA in the recent period.
No significant insider selling has been recorded for TNYA in the recent period.
Based on recent SEC filings, insider sentiment for TNYA is bullish with an Insider Alignment Score of 100/100 and a net flow of $111.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Tenaya Therapeutics, Inc. (TNYA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading TNYA stock, having executed 77 transactions in the past 90 days. The most active insider is David Goeddel V (Executive), who has made 9 transactions totaling $39.6M.
Get notified when executives and directors at TNYA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | Ali Faraz | Executive | Award | 952,250 | $N/A | $0 | |
| Feb 3, 2026 | Ali Faraz | Executive | Award | 158,600 | $N/A | $0 | |
| Feb 3, 2026 | Tingley Whittemore | Chief Medical Officer | Award | 318,500 | $N/A | $0 | |
| Feb 3, 2026 | Tingley Whittemore | Chief Medical Officer | Award | 48,750 | $N/A | $0 | |
| Feb 3, 2026 | Higa Tomohiro | SVP, Finance | Award | 175,500 | $N/A | $0 | |
| Feb 3, 2026 | Higa Tomohiro | SVP, Finance | Award | 29,250 | $N/A | $0 | |
| Nov 17, 2025 | Ali Faraz | Executive | Sale | 3,126 | $1.33 | $4.2K | |
| Nov 17, 2025 | Tingley Whittemore | Executive | Sale | 2,877 | $1.33 | $3.8K | |
| Nov 17, 2025 | Higa Tomohiro | Executive | Sale | 1,367 | $1.33 | $1.8K | |
| Aug 18, 2025 | Ali Faraz | Executive | Sale | 4,920 | $1.25 | $6.2K | |
| Aug 18, 2025 | Ali Faraz | Executive | Sale | 3,893 | $1.25 | $4.9K | |
| Aug 18, 2025 | Ali Faraz | Executive | Sale | 5,720 | $1.25 | $7.2K | |
| Aug 18, 2025 | Tingley Whittemore | Executive | Sale | 1,837 | $1.25 | $2.3K | |
| Aug 18, 2025 | Tingley Whittemore | Executive | Sale | 1,608 | $1.25 | $2.0K | |
| Aug 18, 2025 | Tingley Whittemore | Executive | Sale | 1,608 | $1.25 | $2.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 18 | $111.7M | 99.6% |
Sale(S) | 32 | $405.0K | 0.4% |
Award(A) | 18 | $0 | 0.0% |
Conversion(C) | 9 | $0 | 0.0% |
Insiders at Tenaya Therapeutics, Inc. are accumulating shares at an accelerated pace. With 15 insiders making 77 transactions totaling $111.7M in purchases versus $405.0K in sales, the net buying activity of $111.3M signals strong executive confidence. David Goeddel V (Executive) leads the buying activity with $39.6M in transactions across all time.